Edition:
United Kingdom

Aravive Inc (ARAV.OQ)

ARAV.OQ on NASDAQ Stock Exchange Global Select Market

6.47USD
6:38pm GMT
Change (% chg)

$-0.05 (-0.77%)
Prev Close
$6.52
Open
$6.82
Day's High
$6.82
Day's Low
$6.44
Volume
1,421
Avg. Vol
6,599
52-wk High
$15.15
52-wk Low
$5.01

Chart for

About

Aravive, Inc., formerly Versartis, Inc., is a clinical-stage biotechnology company. The Company is focused on developing therapies that target survival pathways for both solid tumors, as well as hematologic malignancies. Its primary therapeutic focus is the growth arrest-specific 6 (GAS6) - AXL receptor tyrosine kinase (AXL)... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $72.91
Shares Outstanding(Mil.): 11.18
Dividend: --
Yield (%): --

Financials

  ARAV.OQ Industry Sector
P/E (TTM): -- 81.01 29.57
EPS (TTM): -4.54 -- --
ROI: -43.36 -0.53 12.77
ROE: -48.25 -3.22 14.47

Earnings vs. Estimates